Arcellx, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ACLX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
800 Bridge Parkway, Redwood City, California

Insiders trading volume in the past year

Arcellx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $371M Dec 28, 2023
New Enterprise Associates 15, L.P. 10%+ Owner $262M Dec 20, 2022
NEA Partners 15, L.P. 10%+ Owner $262M Dec 20, 2022
Holdings A/S Novo 10%+ Owner $222M Feb 8, 2022
Lewis T. Williams Director $116M Feb 8, 2022
Jill Carroll Director $104M -$60.4M -36.6% May 28, 2024
Sr One Capital Management, Llc 10%+ Owner $91.7M May 11, 2023
Rami Elghandour President, CEO and Chairman of the Board, Director $8.62M -$5.57M -39.2% Apr 1, 2024
Christopher Heery Chief Medical Officer $1.9M -$19.7M -91.2% Sep 5, 2024
Michelle Gilson Chief Financial Officer $1.58M -$2.25M -58.8% Jun 26, 2024
Mohamad Makhzoumi 10%+ Owner $15.6K Dec 20, 2022
Peter W. Sonsini 10%+ Owner $663 Dec 20, 2022
Olivia C. Ware Director $0 -$1.16M -100% May 28, 2024
Kavita Patel Director $0 -$819K -100% Aug 20, 2024
Lance E. Thibault Interim Chief Financial Officer Exhibit 24 - Power of Attorney Feb 3, 2022
Scott D. Sandell 10%+ Owner Dec 23, 2022
David Lubner Director May 28, 2024
Ali Behbahani Director May 28, 2024
Derek Yoon Director May 28, 2024
Anthony A. Florence Jr. 10%+ Owner Dec 20, 2022
Forest Baskett 10%+ Owner Dec 20, 2022

Recent Insider Transactions by Companies or Individuals for Arcellx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.